July 31 (Reuters) - Intellipharmaceutics International Inc IPCI.TO
* Intellipharmaceutics International - on July 28, purported class action complaint was filed in U.S. Court By Shawn Shanawaz
* Intellipharmaceutics International - complaint seeks, among other remedies, unspecified damages, equitable and/or injunctive relief
* Intellipharmaceutics International-complaint filed by Shanawaz on behalf of himself, all others similarly situated against co & 2 of its executive officers
* Intellipharmaceutics - complaint alleges misleading statements or failing to disclose certain info regarding co's new drug application for Rexista